@extends('app')
@section('header_style')
    <style>

    </style>

@endsection()
@section('content')
    <div class="row pt-5">
        <div class="col-md-12 main-section">
            <div class="mb-3">
                <audio controls autoplay>
                    <source src="https://serum-myeloma.s3.amazonaws.com/Audio/01.mp3" type="audio/mp3">
                </audio>
            </div>
            <div class="card border-0">
                <div class="card-body bg-gray-100">
                    <div class="row">
                        <div class="col-md-12">
                            <p>Evidence-Based Approach to the Diagnosis and Management of Multiple myeloma</p>
                            <div class="mt-3"><p class="bold">You Are Eligible for</p>A certificate of completion</div>
                            <div class="mt-3"><p class="bold">Target Audience and Goal Statement</p>
                                <p>This activity is intended for
                                    hematology/oncology specialists, nurses, pharmacists, and other members of the
                                    healthcare team for patients with multiple myeloma.</p>
                                <p>The goal of this activity is to increase the knowledge and competence of
                                    hematologists/oncologists and other clinicians who care for patients with multiple
                                    myeloma in the areas of treatment selection for transplant-ineligible patients,
                                    maintenance therapy, and management of therapy-related adverse events.</p>
                                <p>Upon completion of this activity, participants will have increased knowledge
                                    regarding</p>
                                <ol>
                                    <li>Discussing the MM disease continuum and disease burden.</li>
                                    <li>Reviewing evidence- and guideline-based strategies for diagnostic workups,
                                        genetic/molecular assessments, and risk assessment.
                                    </li>
                                    <li>
                                        Evaluating clinical data for new and emerging therapies to facilitate
                                        selection of optimal treatment options based on current guideline
                                        recommendations and expert recommendations.
                                    </li>
                                    <li>Describing adverse effect profiles of approved therapies to enable incorporation
                                        of best practices for providing supportive care measures to mitigate/manage side
                                        effects associated with specific therapies.
                                    </li>
                                    <li>Devising personalized treatment plans based on patient-, disease-, and
                                        treatment-related factors while providing opportunities for patient engagement,
                                        education, and shared decision-making.
                                    </li>
                                </ol>
                            </div>
                            <div>
                                <p class="bold">Disclosures</p>
                                <p>Libertas Vita, LLC requires everyone who is in a position to control the content of
                                    an education activity to disclose all relevant financial relationships with any
                                    commercial interest. The ACCME defines "relevant financial relationships" as
                                    financial relationships in any amount occurring within the past 12 months, including
                                    financial relationships of a spouse or life partner, that could create a conflict of
                                    interest.</p>
                                <p>Libertas Vita, LLC encourages Authors to identify investigational products or
                                    off-label uses of products regulated by the US Food and Drug Administration at first
                                    mention and where appropriate in the content.</p>
                            </div>
                            <div>
                                <p class="bold">Moderator</p>
                                <p>Saad Z. Usmani, MD MBA FACP</p>
                                <p>
                                    Chief, Plasma Cell Disorders Division; Director, Clinical Research for Hematologic
                                    Malignancies
                                    Clinical Professor of Medicine
                                    Leukemia Lymphoma Society Scholar in Clinical Research
                                    Department of Hematologic Oncology and Blood Disorders
                                    Levine Cancer Institute/Atrium Health, Charlotte, NC
                                </p>
                                <p>
                                    Disclosure: Saad Z. Usmani, MD MBA FACP, has disclosed the following relevant
                                    financial relationships:
                                    Served as a paid speaker for: Amgen; BMS/Celgene; Janssen; Sanofi; Takeda.
                                </p>
                            </div>
                            <div>
                                <p class="bold">Reviewers</p>
                                <p>María-Victoria Mateos, MD PhD</p>
                                <p>Director of the Myeloma Program
                                    Department of Hematology
                                    Salamanca's University, Spain
                                </p>
                                <p>Disclosure: María-Victoria Mateos, MD PhD, has disclosed the following relevant
                                    financial relationships:
                                    Served as a paid speaker for: Janssen; Celgene; Amgen; Takeda; Oncopeptides; Sanofi;
                                    Adaptive; Karyopharm.
                                </p>
                                <p>Andrew Spencer, MBBS FRACP FRCPA DM</p>
                                <p>Head of the Malignant Haematology & Stem Cell Transplantation Service
                                    Professor of Haematology at Monash University, Head of the Myeloma Research Group
                                    and Co-Director of the ACRF Blood Cancer Therapeutics Centre at the Australian
                                    Centre for Blood Diseases
                                    The Alfred Hospital, Australia
                                </p>
                                <p>
                                    Disclosure: Andrew Spencer, MBBS FRACP FRCPA DM, has disclosed the following
                                    relevant financial relationships:
                                    Served as a paid speaker for: BMS; Janssen.
                                    Served as an advisory Board Member: BMS; Janssen; Secura Bio; AbbVie; Haemalogix;
                                    Pfizer; Roche; Amgen; TheraMyc; Antegene.
                                    Received grant/research support: BMS, Janssen; Amgen; Haemalogix; Abbvie; PharmaMar.
                                    Received honoraria: BMS; Janssen; Amgen; Secura Bio; AbbVie; Haemalogix; Pfizer;
                                    Roche; TheraMyc; Antegene
                                </p>
                            </div>
                            <div>
                                <p class="bold">Editor</p>
                                <p>Sophia Whitman, MD
                                    Medical Education Director, Libertas Vita, LLC
                                </p>
                            </div>
                            <div>
                                <p class="bold">CME Reviewer</p>
                                <p>Rita Aresta, MD
                                    Associate Director, Accreditation and Compliance, Libertas Vita, LLC
                                </p>
                                <p>Disclosure: Rita Aresta, MD, has disclosed no relevant financial relationships.</p>
                                <p>Libertas Vita, LLC staff have disclosed that they have no relevant financial
                                    relationships.</p>
                                <p>Peer Reviewer
                                    This activity has been peer reviewed and the reviewer has disclosed the following
                                    relevant financial relationships:
                                </p>
                            </div>
                            <div>
                                <p class="bold">Instructions for participation</p>
                                <p>There are no fees for participating in educational activities offered by Libertas
                                    Vita.</p>
                                <p>Follow these steps:</p>
                                <ul>
                                    <li>Read the target audience, learning objectives, and author disclosures.</li>
                                    <li>Study the educational content.</li>
                                    <li>Online, choose the best answer to each test question. We encourage you to
                                        complete the Activity Evaluation to provide feedback for future activities and
                                        formats.
                                    </li>
                                    <li>Your participation certificate will be delivered to you by email.</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="row">
        <div class="col-md-12">
            <div class="mt-5">
                <a href="{{ route('prequiz') }}" class="btn btn-primary py-3">Start Activity</a>
            </div>
        </div>
    </div>
@endsection()
@section('footer_script')
    <script>
        $(function(){
            audioElement.play();
        })
    </script>
@endsection()
